Nektar Therapeutics (NKTR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 96,363 | 81,224 | 85,424 | 106,752 | 194,905 |
| Marketable Securities | 1,228,499 | 1,414,448 | 1,429,955 | 1,281,913 | 1,140,445 |
| Receivables | 36,802 | 41,205 | 37,299 | 42,894 | 43,213 |
| Inventories | 12,665 | 13,720 | 13,188 | 11,778 | 11,381 |
| Other current assets | 47,221 | 28,227 | 30,951 | 46,777 | 47,743 |
| TOTAL | $1,421,550 | $1,578,824 | $1,596,817 | $1,490,114 | $1,437,687 |
| Non-Current Assets | |||||
| PPE Net | 65,665 | 64,614 | 65,453 | 58,158 | 48,851 |
| Investments And Advances | 279,119 | 231,082 | 276,305 | 455,867 | 582,889 |
| Intangibles | 76,501 | 76,501 | 76,501 | 76,501 | 76,501 |
| Other Non-Current Assets | 134,521 | 137,273 | 84,577 | 85,842 | 4,244 |
| TOTAL | $555,806 | $509,470 | $502,836 | $676,368 | $712,485 |
| Total Assets | $1,977,356 | $2,088,294 | $2,099,653 | $2,166,482 | $2,150,172 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 252,891 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 19,234 | 21,963 | 9,346 | 11,012 | 5,854 |
| Accrued Expenses | 51,397 | 74,283 | 76,553 | 61,341 | 52,676 |
| Other current liabilities | N/A | N/A | N/A | N/A | 493 |
| TOTAL | $353,893 | $125,350 | $113,370 | $99,718 | $82,002 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 248,257 | 247,821 | 247,386 | 246,950 |
| Deferred Revenues | 5,517 | 8,392 | 9,892 | 11,092 | 13,892 |
| Other Non-Current Liabilities | 215,518 | 219,197 | 173,278 | 176,527 | 92,901 |
| TOTAL | $218,072 | $474,233 | $429,128 | $433,253 | $350,595 |
| Total Liabilities | $571,965 | $599,583 | $542,498 | $532,971 | $432,597 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 11,843 | 11,734 | 11,691 | 11,626 | 11,613 |
| Common Shares | 17 | 17 | 17 | 17 | 17 |
| Retained earnings | -1,864,718 | -1,751,280 | -1,652,472 | -1,542,563 | -1,424,051 |
| Other shareholders' equity | -1,005 | -1,186 | -788 | -2,716 | -6,316 |
| TOTAL | $1,405,391 | $1,488,711 | $1,557,155 | $1,633,511 | $1,717,575 |
| Total Liabilities And Equity | $1,977,356 | $2,088,294 | $2,099,653 | $2,166,482 | $2,150,172 |